Mode
Text Size
Log in / Sign up
N/A N=167 Randomized Single-blind Treatment

Restoring the Anatomic Tension Relationship of the Long Head of the Biceps During Tenodesis

Biceps Tendon Disorder · Tendinosis · Rotator Cuff Injuries

Enrolled (actual)
167
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups — 47.1; 37.1 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Anatomic Long Head of Biceps Tensioning Technique (Procedure); Traditional Long Head of Biceps Tensioning Technique (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Loyola University
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups
78.3; 77.3
PRIMARY
Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups
78.3; 77.3
PRIMARY
Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups
78.3; 77.3
PRIMARY
Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups
78.3; 77.3
PRIMARY
Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups
78.3; 77.3
SECONDARY
Comparison of Visual Analog Scale (VAS) Pain Score Between Treatment and Control Groups
2.2; 2.9
SECONDARY
Comparison of Visual Analog Scale (VAS) Pain Score Between Treatment and Control Groups
2.2; 2.9
SECONDARY
Comparison of Visual Analog Scale (VAS) Pain Score Between Treatment and Control Groups
2.2; 2.9
SECONDARY
Comparison of Visual Analog Scale (VAS) Pain Score Between Treatment and Control Groups
2.2; 2.9
SECONDARY
Comparison of Visual Analog Scale (VAS) Pain Score Between Treatment and Control Groups
2.2; 2.9
SECONDARY
Comparison of Active Forward Flexion Between Treatment and Control Groups
150.3; 139.0
SECONDARY
Comparison of Active Forward Flexion Between Treatment and Control Groups
150.3; 139.0
SECONDARY
Comparison of Active Forward Flexion Between Treatment and Control Groups
150.3; 139.0
SECONDARY
Comparison of Active Forward Flexion Between Treatment and Control Groups
150.3; 139.0
SECONDARY
Comparison of Active External Rotation Between Treatment and Control Groups
45.4; 43.6
SECONDARY
Comparison of Active External Rotation Between Treatment and Control Groups
45.4; 43.6
SECONDARY
Comparison of Active External Rotation Between Treatment and Control Groups
45.4; 43.6
SECONDARY
Comparison of Active External Rotation Between Treatment and Control Groups
45.4; 43.6

Summary

The goal of this clinical trial is to determine the clinical impact of restoring the anatomic-tension relationship of the long head of the biceps (LHB) when performing a biceps tenotomy and tenodesis. The main question it aims to answer is whether anatomic tensioning will improve functional outcome scores and decrease postoperative complications. The investigators hypothesize that through a standardized method of anatomically tensioning the LHB tendon during tenodesis, patient outcomes will improve. Researchers will compare these outcomes to a control group receiving the traditional tensioning technique. Participants will be randomized to either the anatomic tensioning treatment group or the traditional tensioning control group.

Eligibility Criteria

Inclusion Criteria

  • Patients at least 18 years of age undergoing arthroscopic shoulder surgery
  • Operations that occur at Loyola University Medical Center (Maywood, IL), Loyola Ambulatory Surgery Center (Maywood, IL), or Gottlieb Memorial Hospital

Exclusion Criteria

  • Previous shoulder surgery involving the long head of the biceps tendon
  • Younger than 18 years old
  • Current pregnancy. As per standard protocol with all surgeries, a urine pregnancy test is performed prior to surgery. If positive, the surgery will be cancelled and the patient will be excluded from the research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06571695). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search